Divalproex Sodium Tablet, Extended Release
Product Images NDC 68788-8358

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68788-8358). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sodium Er Tab 500mg (83a77f60 Ed58 4fa0 A584 E6a0c767d19d 00)

This is a prescription drug package label for Divalproex Sodium ER Tab 500mg, which is the generic for Depakote ER. The oval, gray tablet is imprinted with 1089 and is manufactured by Lupin Pharmaceuticals, Inc. The label also contains information regarding the package size, expiration date, lot number, batch number, and product number. There are cautionary warnings on the label and instructions on how to take the medication. The label also gives directions on how to fill out a billing chart log for the patient.*

FDA Label Image

Image 1 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 01)

FDA Label Image

Image 2 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 02)

The text appears to be a graph showing the reduction in CPS (cycles per second) rate for patients taking Divalproex Sodium Delayed-Release compared to a placebo. The graph also shows the percentage of patients experiencing improvement, no change, or worsening symptoms.*

FDA Label Image

Image 3 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 03)

FDA Label Image

Image 4 (D95f9b1b F1e4 4ae4 A215 7317fb1ca565 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.